{
  "id": "clinical#management_53a9429d",
  "content": "Neurocognitive Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . .285\nPersonality Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .321\nParaphilic Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .333\nOther Mental Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . .341\nMedication-Induced Movement Disorders\nand Other Adverse Effects of Medication . . . . . . . . . . . . .345\nOther Conditions That May Be a Focus of\nClinical Attention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .355\nNeurodevelopmental\nDisorders\nIntellectual Disabilities\nIntellectual Disability\n(Intellectual Developmental Disorder)",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Management Neurocognitive Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . .285\nPersonality Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .321\nParaphilic Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .333\nOther Mental Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . .341\nMedication-Induced Movement Disorders\nand Other Adverse Effects of Medication . . . . . . . . . . . . .345\nOther Conditions That May Be a Focus of\nClinical Attention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .355\nNeurodevelopmental\nDisorders\nIntellectual Disabilities\nIntellectual Disability\n(Intellectual Developmental Disorder) Neurocognitive disorders . ."
}